Covid-19 and performance disclosure: does governance matter?

DOIhttps://doi.org/10.1108/IJAIM-04-2021-0086
Published date11 October 2021
Date11 October 2021
Pages776-792
Subject MatterAccounting & finance,Accounting/accountancy,Accounting methods/systems
AuthorMahmoud Elmarzouky,Khaldoon Albitar,Khaled Hussainey
Covid-19 and performance
disclosure: does governance matter?
Mahmoud Elmarzouky
Kingston Business School, Kingston University, London, UK, and
Khaldoon Albitar and Khaled Hussainey
Portsmouth Business School, University of Portsmouth, Portsmouth, UK
Abstract
Purpose This paper aims to investigatewhether Covid-19 related information is associated with a higher
level of performance disclosure in the annual reports. Furthermore, it examines the moderating effect of
corporate governance on the relationship between Covid-19 and the performance disclosure by using three
governancemechanisms: board size, board independence and gender diversity.
Design/methodology/approach The authors use quantitativecontent analysis. The authors applied
an automated textual analysis technique to measure the level of Covid-19 information and performance
disclosurefor the UK Financial Times Stock Exchange all-share non-f‌inancialf‌irms.
Findings The authors found a signif‌icant positive relationship between the Covid-19 disclosure and
the f‌irm performance disclosure in the annual reports. The authors also f‌ind that both board
independence and gender diversity moderatethe relationship between the Covid-19 related information
and the level of performance disclosure in the annual reports. The authors further run a robustness
analysis, which conf‌irms the main results.
Practical implications The f‌inding is benef‌icialfor the regulatory setters to better understand whether
f‌irms provide generic or meaningful Covid-19 information linked to the f‌irms performance. The unique
f‌indings ofthis paper are relevant to regulators, governments,management, shareholders and academics.
Originality/value The authors contribute to the literature in a unique and core research area not
researched previously.The paper links the Covid-19 disclosure with the f‌irm performance from the corporate
narrative perspective. The paperunderlines governance factors as a moderating role in this relationship by
consideringthree main mechanisms: board size, board independenceand gender diversity.
Keywords Textual analysis, Board independence, Gender diversity, Board size,
Covid-19 disclosure, Performance disclosure
Paper type Research paper
1. Introduction
The UK faces the most challenging economic turbulence,as the global f‌inancial crisis (GFC)
(Goodell, 2020:Albitaret al., 2021a). Covid-19 pandemic is acting as a catalyst for increasing
uncertainty about f‌irm performance. Whilst the f‌inancial institutionsperformance mainly
caused the f‌inancial crisis, the Covid-19 pandemic is a global natural crisis and has no
institution sectorto be blamed. The UK gross domestic product growth hasdeclined by 35%
in some sectors such as construction, whilstother industries are not negatively affected. To
deliver this message to stakeholders, managers may associate their Covid-19 information
with more performance disclosure. Covid-19 is classif‌ied as systematic risk, so managers
would like to disclose their ability to mitigate this risk. The UK also has imposed various
levels of lockdowns, which increase the uncertainty about f‌irm performance. According to
the signalling theory (Spence, 2002;Connelly et al.,2011), business entities may disclose
Covid-19 related information associated with performance disclosure to send positive
IJAIM
29,5
776
Received29 April 2021
Revised7 August 2021
Accepted6 September 2021
InternationalJournal of
Accounting& Information
Management
Vol.29 No. 5, 2021
pp. 776-792
© Emerald Publishing Limited
1834-7649
DOI 10.1108/IJAIM-04-2021-0086
The current issue and full text archive of this journal is available on Emerald Insight at:
https://www.emerald.com/insight/1834-7649.htm
signals to stakeholders and markets regarding handling the current situation and provide
more assurance about the f‌irm future performance.
Based on the Trueman theory (Trueman, 1986), we argue that managers will
demonstrate their skills and abilities by increasing the level of performance disclosure
associated with any communicated Covid-19 information. This is to provide stakeholders
with a positive assessment of their management abilities. The performance disclosure will
predict any changes caused by the Covid-19 pandemic and, therefore, aid in selecting
appropriate mitigation plans. Additionally, performance disclosure indicates a strong
position for the f‌irm in the future, whichmay entail a higher share price being interpreted by
the capital markets (Trueman,1986).
Financial reporting council (FRC) hasissued a framework on corporate governance and
Covid-19 reporting to encourage f‌irms to provide information on how they impacted and
reacted to the Covid-19 pandemic. FRC has also issued a framework on corporate
governance and reporting to companies. It is believed that the narrative sections of the
annual reports could provide an opportunity for companies to communicate the impact of
the Covid-19 pandemic on their activities and the proposed actions to be taken. The
framework highlights the importance of communicating meaningful information (rather
than generic information) in the narrative sections of the annual reports. We are, therefore,
motivated by considering whether companies provide meaningful or generic information
related to Covid-19and how this information is linked to performance-related information.
Recently published research related to Covid-19 were mainly focussed on either the
future of f‌inancial reporting (Hassan et al., 2021) or the theoretical perception of Covid-19
across f‌inancial markets,banking and insurance entities and government and public entities
(Nabity-Grover, et al., 2020;Donthu and Gustafsson, 2020) or the f‌inance reaction on the
market such as stock return (Broadstocket al., 2020;Erdem, 2020:Wang and Xing, 2020)or
stock volatility (Mazur et al.,2020;Salisu and Vo, 2020). At the same time, other research
focussed on f‌inancial performancepre and post Covid-19 (Khatib and Nour, 2021) or the ESG
disclosure impacts on f‌inancial performance during the Covid-19 crisis (Broadstock et al.,
2020) or discusses the determinants of Covid-19 in the CSR reports (Albitar et al., 2021b).
which raises whether Covid-19 related information associates with a higher level of
performance disclosurein the annual reports. We examined how Covid-19 disclosureaffects
the f‌irms performance disclosure. Furthermore, we examine the moderat ing effect of corporate
governance in enhancing the relationship between Covid-19 and the performance disclosure by
using board size, board independence and gender diversity. Furthermore, we run a robustness
check using subsample groups of various board size, board independence and gender diversity
to better understand the association between the Covid-19 disclosure and f‌irm performance
disclosure. We use the performance disclosure indexto capture the performance score in the
annual reports (El-Haj et al., 2016). Further, we used our self-developed index to measure Covid-
19 disclosure.
We f‌ind a signif‌icant positive association between the level of Covid-19 disclosure and
performance disclosure in annual reports. We also found that board independence and
gender diversity play acrucial role in the relationship between Covid-19 disclosureand f‌irm
performance disclosure. Unlike the board size, our data could not suggest any moderating
effect of the board size in enhancing the relationship between Covid-19 and performance
disclosure. Moreover, following the literature, we use a subsample group to understand
whether the effect of Covid-19 disclosure on performancevaries with changes in board size,
board independence and gender diversity (Ahmedand Courtis, 1999;Chen and Jaggi, 2000;
Ntim et al.,2013;Albitar et al., 2020). Interestingly, our results show that the relationship
between the Covid-19 disclosureand performance disclosure is positive and signif‌icant with
Covid-19 and
performance
disclosure
777

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT